Cardiac Rehabilitation in Cardiomyopathies
The Effectiveness of a Cardiac Rehabilitation in Patients With Cardiomyopathy
1 other identifier
interventional
9
1 country
1
Brief Summary
This quantitative study aimed to evaluate the respiratory muscle strength, pulmonary function, cardiovascular function, and impact on quality of life in patients after cardiac rehabilitation associated with the diaphragmatic muscle training.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at below P25 for not_applicable
Started Jun 2008
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
June 1, 2008
CompletedPrimary Completion
Last participant's last visit for primary outcome
April 1, 2009
CompletedStudy Completion
Last participant's last visit for all outcomes
June 1, 2009
CompletedFirst Submitted
Initial submission to the registry
August 25, 2009
CompletedFirst Posted
Study publicly available on registry
August 26, 2009
CompletedOctober 6, 2009
October 1, 2009
10 months
August 25, 2009
October 5, 2009
Conditions
Keywords
Outcome Measures
Primary Outcomes (1)
The effectiveness of a cardiac rehabilitation in patients with cardiomyopathy, evaluating the respiratory muscle strength, pulmonary function, cardiovascular function, and impact on quality of life.
8 weeks / Twice a week
Study Arms (1)
Cardiac Rehabilitation
EXPERIMENTAL9 patients with cardiomyopathy in functional class III or IV, submitted to an 8-week program with exercises and respiratory muscle training.
Interventions
Stretching and aerobic exercises and respiratory muscle training with a Threshold ® device, with load of 40% of the maximal inspiratory pressure (MIP), two times a week during one hour.
Eligibility Criteria
You may qualify if:
- Clinical diagnosis of Cardiomyopathies in functional class III or IV (New York Heart Association)
- Aged over 18 years
- Body mass index below 30 kg/m2
You may not qualify if:
- Confused and depressed patients
- Cardiac instability and worsening dyspnea after initiation of treatment
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Fortaleza Universitylead
- Edson Queiroz Foundationcollaborator
Study Sites (1)
Fortaleza University - Nucleus of Integrated Medical Attention
Fortaleza, Ceará, Brazil
MeSH Terms
Conditions
Interventions
Condition Hierarchy (Ancestors)
Intervention Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
Davi S Sales, Bachelor
Fortaleza University
- STUDY DIRECTOR
Daniela GB Mont'Alverne, Doctor
Fortaleza University
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- SINGLE GROUP
- Sponsor Type
- OTHER
Study Record Dates
First Submitted
August 25, 2009
First Posted
August 26, 2009
Study Start
June 1, 2008
Primary Completion
April 1, 2009
Study Completion
June 1, 2009
Last Updated
October 6, 2009
Record last verified: 2009-10